Scott A. Armstrong, MD, PHDD

Dana-Farber Cancer Institute; Boston, MA – Chair, Department of Pediatric Oncology

The goal of Scott Armstrong’s research program is to define genetic and epigenetic programs that control the extensive self-renewal properties associated with leukemia and other cancers. This knowledge is then used to develop rational approaches for potential new therapies. Experiments incorporate the use of sophisticated mouse models of leukemia and the characterization of human leukemia cells.